Index tracked: MSCI World Net Total Return USD Index
TER
0.14%+ trans. 0.01%
Fund size
71 m EUR
Tracking difference
—not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 30 Sept 2025 · costs from the KID as of 2 Sept 2026 · 1,254 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Sub-Fund is passively managed. The objective of the Sub- Fund is to track the performance of the MSCI World Index (the "Index"). The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a broad global equity index representative of the large and mid-cap markets across developed countries. The Index is a net total return index, meaning that dividends net of tax paid by the index constituents are included in the Index return. More information about the composition of the…
Performance since series start (in euro) — base 100
7 Oct 2025 → 8 Sept 2026 · dividends reinvested where declared by the issuer
High 116 (13 Aug 2026) · low 96 (30 Mar 2026) · last 114. Past performance is not indicative of future results.
RebalixMWHE · IE000H7PE775 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: hedged class: the issuer’s published index is unhedged — the gap would measure the exchange rate, not replication. We don’t show it
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 1,254 securities · top-10 weight = 26.6%
The live sheet, always up to date rebalix.com/en/etf/IE000H7PE775 Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.